D'Agostino, M ; Cairns, DA ; Lahuerta, JJ...
https://eprints.whiterose.ac.uk/194117/1/jco.21.02614.pdf.  , 2022

van de Donk, NWCJ ; Delforge, M ; Agha, M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012122/.  , 2022

D'Agostino, M ; Cairns, DA ; Lahuerta, JJ...
Journal of Clinical Oncology, 2022, pp. JCO2102614 -.  , 2022

Mateos, M ; Hari, P ; Bahlis, N...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012119/.  , 2022

van de Donk, NWCJ ; Pawlyn, C ; Yong, KL
https://discovery.ucl.ac.uk/id/eprint/10122628/3/Yong_Lancet%20Seminar%20Revision%20FInal%2030Aug%20changes%20accepted.pdf.  , 2021

Nooka, AK ; Weisel, K ; van de Donk, NWCJ...
issn:1479-6694.  , 2021

Groen K ; van de Donk NWCJ ; Stege CAM..
https://www.dovepress.com/carfilzomib-for-relapsed-and-refractory-multiple-myeloma-peer-reviewed-article-CMAR.  , 2019

Groen, K ; van de Donk, Nwcj ; Stege, Cam..
Groen , K , van de Donk , N , Stege , C , Zweegman , S & Nijhof , I S 2019 , ' Carfilzomib for relapsed and refractory multiple myeloma ' , Cancer management and research , vol. 11 , pp. 2663-2675 . https://doi.org/10.2147/CMAR.S150653.  , 2019

Mateos, M-V ; Ludwig, H ; Bazarbachi, A...
https://discovery.ucl.ac.uk/id/eprint/10123029/1/Insights_on_Multiple_Myeloma_Treatment_Strategies.7.pdf.  , 2019

Groen, K ; van de Donk, NWCJ ; Stege, CAM..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450182/.  , 2019

van de Donk, NWCJ ; Palumbo, A ; Johnsen, HE...
Haematologica, 2014, 99 (6), pp. 984 - 996.  , 2018

Ludwig, H ; Delforge, M ; Facon, T...
https://eprints.whiterose.ac.uk/149403/7/s41375-018-0040-1.pdf.  , 2018